Bronstein, Gewirtz & Grossman, LLC Encourages Cellebrite DI Ltd. (CLBT) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / November 18, 2026 /Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cellebrite DI Ltd. ("Cellebrite" or "the Company") (NASDAQ:CLBT). Investors who purchased Cellebrite securities are encouraged to obtain additional information and assist the investigation by visiting the firm 's site: bgandg.com/cases/cellebrite-di-ltd-clbt-investigation.

Cellebrite Investigation Details
On November 12, 2026, Cellebrite reported third-quarter revenue of $149.0 million, exceeding FactSet 's estimate of $145.8 million, and earnings of $0.17 per share, above the estimated $0.09 per share. However, the Company also lowered its full-year revenue guidance for the second time, following an earlier reduction in August, and projected fourth-quarter revenue of $145 million to $150 million. Following this news, Cellebrite shares initially rose before reversing to a loss of approximately 14% during afternoon trading on November 12, 2026.
What 's Next for Cellebrite Investors?
If you are aware of any facts relating to this investigation or purchased Cellebrite securities, you can assist this investigation by visiting the firm 's site: bgandg.com/cases/cellebrite-di-ltd-clbt-investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Cellebrite Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys ' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Cellebrite Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | info@bgandg.com
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE:Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.











